Workflow
江中药业(600750) - 2014 Q3 - 季度财报
JZYYJZYY(SH:600750)2014-10-24 16:00

Financial Performance - Net profit attributable to shareholders rose by 11.54% to CNY 155,225,909.83 year-on-year[7] - Operating income grew by 9.29% to CNY 2,053,536,041.56 for the year-to-date period[7] - Basic earnings per share increased by 13.95% to CNY 0.5097[7] - Total operating revenue for the third quarter reached ¥664.63 million, an increase of 13.73% compared to ¥584.29 million in the same period last year[33] - Net profit for the third quarter was ¥59.16 million, representing a 147.00% increase from ¥23.85 million in the same quarter last year[35] - The company reported a total profit of ¥71.96 million for the third quarter, compared to ¥29.53 million in the same quarter last year[35] Cash Flow - Cash flow from operating activities surged by 183.39% to CNY 280,973,002.56 compared to the same period last year[7] - The net cash flow from operating activities for the reporting period is 280.97 million yuan, an increase of 181.82 million yuan, representing a growth rate of 183.39%, primarily due to increased cash received from sales of goods or services[15] - Operating cash flow for the first nine months of 2014 was CNY 372,181,006.07, an increase of 132.7% compared to CNY 159,957,097.49 in the same period last year[44] - Total cash inflow from operating activities reached CNY 1,944,699,665.57, up from CNY 1,530,839,860.16 year-on-year, reflecting a growth of 27.0%[44] - The company reported a net decrease in cash and cash equivalents of -CNY 66,032,785.99 for the quarter, compared to -CNY 116,958,030.26 in the same quarter last year[45] Assets and Liabilities - Total assets increased by 6.63% to CNY 3,190,734,325.81 compared to the end of the previous year[7] - Total liabilities increased to CNY 1,168,053,413.87 from CNY 859,147,505.94, reflecting a growth of approximately 36%[28] - The company's equity decreased to CNY 2,022,680,911.94 from CNY 2,133,249,679.50, a decline of about 5.2%[28] - The ending balance of short-term borrowings is 135 million yuan, an increase of 110 million yuan, representing a growth rate of 440%, primarily due to increased bank borrowings during the reporting period[13] Receivables and Expenses - Accounts receivable increased by 140.06% to CNY 157,500,000, primarily due to growth in receivables from a subsidiary[12] - Other receivables rose by 229.17% to CNY 24,520,000, attributed to increased unbilled expenses and funding for employee housing[12] - The ending balance of sales expenses for the current period is 726.24 million yuan, an increase of 309.37 million yuan, representing a growth rate of 74.21%, mainly due to increased market investment during the reporting period[14] - Sales expenses for the third quarter were ¥224.81 million, a 63.93% increase from ¥137.14 million year-over-year[35] Investments and Financial Strategy - The company plans to use up to 200 million yuan of idle funds for short-term financial investments to improve fund utilization efficiency and reduce financial costs[16] - The company has committed to distributing at least 20% of the net profit attributable to shareholders in cash annually for the next three years, provided there are no major investment plans or cash expenditures[17] - The company has provided loans of up to 100 million yuan to its wholly-owned subsidiary for business development needs, with a loan of 60 million yuan already issued during the reporting period[16]